î
îŒ
ãã°ã€ã³
î
Clearmind Medicine Inc
CMND0.804USD
+0.084+11.67%
çµå€Â 03/27, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
9.83Kæ䟡ç·é¡
0.00çŽè¿12ã¶æPER
î
詳现æ å ± Clearmind Medicine Inc äŒæ¥å
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Companyâs intellectual portfolio consists of 19 patent families including 31 granted patents.
Clearmind Medicine Incã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãCMND
äŒç€ŸåClearmind Medicine Inc
äžå Žæ¥Aug 10, 2021
æé«çµå¶è²¬ä»»è
ãCEOãZuloff-Shani (Adi)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
決ç®ææ«Aug 10
æ¬ç€Ÿæåšå°101-1220 West 6Th Avenue
éœåžVANCOUVER
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœCanada
éµäŸ¿çªå·V6H 1A5
é»è©±çªå·16042601566
ãŠã§ããµã€ãhttps://www.clearmindmedicine.com/
äŒæ¥ã³ãŒãCMND
äžå Žæ¥Aug 10, 2021
æé«çµå¶è²¬ä»»è
ãCEOãZuloff-Shani (Adi)
Clearmind Medicine Incã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
4.62K
+78.43%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
1.87K
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
935.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
713.00
+13.04%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
4.62K
+78.43%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
1.87K
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
935.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
713.00
+13.04%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Thu, Mar 12
æŽæ°æå»: Thu, Mar 12
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Capitalink Ltd.
2.18%
L.I.A. Pure Capital Ltd
1.36%
AdvisorShares Investments, LLC
0.44%
Shani (Adi Zuloff)
0.31%
Weiss (Amitay)
0.31%
ä»ã®
95.39%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Capitalink Ltd.
2.18%
L.I.A. Pure Capital Ltd
1.36%
AdvisorShares Investments, LLC
0.44%
Shani (Adi Zuloff)
0.31%
Weiss (Amitay)
0.31%
ä»ã®
95.39%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Corporation
3.54%
Individual Investor
0.92%
Investment Advisor
0.44%
ä»ã®
95.10%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Mon, Dec 8
æŽæ°æå»: Mon, Dec 8
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q4
18
281.13K
2.83%
--
2025Q3
20
281.13K
17.81%
-308.29K
2025Q2
21
589.42K
18.96%
-12.36K
2025Q1
18
601.77K
18.55%
-350.88K
2024Q4
18
612.80K
20.27%
-89.61K
2024Q3
17
702.42K
8.27%
+411.62K
2024Q2
15
290.80K
5.30%
+12.32K
2024Q1
15
281.81K
3.72%
+163.87K
2023Q4
13
96.03K
1.96%
+64.13K
2023Q3
13
31.90K
2.51%
+20.39K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Capitalink Ltd.
149.51K
9.97%
+66.83K
+80.83%
Dec 03, 2025
L.I.A. Pure Capital Ltd
149.51K
9.97%
+66.83K
+80.83%
Dec 03, 2025
AdvisorShares Investments, LLC
5.61K
0.37%
+461.00
+8.95%
Sep 30, 2025
Shani (Adi Zuloff)
1.36K
0.09%
+1.31K
+3128.57%
Oct 31, 2024
Weiss (Amitay)
996.00
0.07%
--
--
Nov 20, 2025
Shachar (Yehonatan Samuel)
312.00
0.02%
--
--
Nov 20, 2025
Rootenberg (Alan)
620.00
0.04%
+383.00
+161.60%
May 13, 2025
RBC Dominion Securities, Inc.
14.00
0%
--
--
Sep 30, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
AdvisorShares Psychedelics ETF
1.16%
Fidelity Nasdaq Composite Index ETF
0%
AdvisorShares Psychedelics ETF
æ¯ç1.16%
Fidelity Nasdaq Composite Index ETF
æ¯ç0%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
Dec 11, 2025
Merger
40â1
Nov 21, 2023
Merger
30â1
Nov 21, 2023
Merger
30â1
Nov 21, 2023
Merger
30â1
Nov 21, 2023
Merger
30â1
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
Dec 11, 2025
Merger
40â1
Nov 21, 2023
Merger
30â1
Nov 21, 2023
Merger
30â1
Nov 21, 2023
Merger
30â1
Nov 21, 2023
Merger
30â1
